Clover Health Investments, Corp.
CLOV
$3.06
-$0.025-0.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 84.30% | 79.84% | 59.76% | 52.63% | 52.50% |
| Total Depreciation and Amortization | -41.95% | -46.95% | 94.27% | 105.58% | 408.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 759.14% | 55.66% | -112.93% | -99.20% | -90.79% |
| Change in Net Operating Assets | -10.64% | -49.17% | 66.12% | -188.46% | -149.82% |
| Cash from Operations | 96.27% | 124.09% | 22.96% | -255.90% | -31.60% |
| Capital Expenditure | -66.58% | -166.44% | 79.32% | 82.68% | 82.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.85% | -98.49% | -3.66% | 17.08% | 56.09% |
| Cash from Investing | -99.78% | -99.60% | 24.14% | 68.66% | 102.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 269.87% | -21.57% | -80.43% | -96.61% | -84.25% |
| Repurchase of Common Stock | -610.32% | -193.62% | -126.13% | -152.84% | -93.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -626.66% | -242.43% | -115.40% | -111.63% | -107.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.79% | 285.71% | -104.94% | -301.99% | -11,966.23% |